{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:06:14Z","timestamp":1787497574911,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.japh.2021.12.001","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T02:38:58Z","timestamp":1638844738000},"page":"717-726.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Factors associated with early nonpersistence among patients experiencing side effects from a new medication"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-5026","authenticated-orcid":false,"given":"Qais","family":"Alefan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenzhen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-3212","authenticated-orcid":false,"given":"Lisa M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2197-0463","authenticated-orcid":false,"given":"Dean","family":"Eurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niteesh","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-5913","authenticated-orcid":false,"given":"David F.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8 Suppl 3","key":"10.1016\/j.japh.2021.12.001_bib2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","article-title":"Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases","volume":"51","author":"Raebel","year":"2013","journal-title":"Med Care"},{"issue":"7653","key":"10.1016\/j.japh.2021.12.001_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.japh.2021.12.001_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"issue":"7\u20138","key":"10.1016\/j.japh.2021.12.001_bib5","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"13","key":"10.1016\/j.japh.2021.12.001_bib6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2017.07.783","article-title":"Adherence tradeoff to multiple preventive therapies and all-cause mortality after acute myocardial infarction","volume":"70","author":"Korhonen","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.japh.2021.12.001_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamacardio.2018.4936","article-title":"Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease","volume":"4","author":"Rodriguez","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.japh.2021.12.001_bib8","doi-asserted-by":"crossref","first-page":"n1493","DOI":"10.1136\/bmj.n1493","article-title":"Medication adherence in cardiovascular medicine","volume":"374","author":"Simon","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.japh.2021.12.001_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ajh.2011.198","article-title":"First-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational study","volume":"25","author":"Evans","year":"2012","journal-title":"Am J Hypertens"},{"issue":"5 Pt 1","key":"10.1016\/j.japh.2021.12.001_bib10","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1475-6773.2009.00989.x","article-title":"New prescription medication gaps: a comprehensive measure of adherence to new prescriptions","volume":"44","author":"Karter","year":"2009","journal-title":"Health Serv Res"},{"issue":"6","key":"10.1016\/j.japh.2021.12.001_bib11","first-page":"487","article-title":"Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics","volume":"13","author":"Pedan","year":"2007","journal-title":"J\u00a0Manag Care Pharm"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2021.12.001_bib12","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1517\/14740338.2014.947260","article-title":"Adherence to therapy and adverse drug reactions: is there a link?","volume":"13","author":"Leporini","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.japh.2021.12.001_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archinte.166.2.155","article-title":"Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects","volume":"166","author":"Rief","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.japh.2021.12.001_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005041","article-title":"Medication discontinuation in the IMPROVE-IT trial","volume":"12","author":"Navar","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.japh.2021.12.001_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejca.2018.03.020","article-title":"Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: results of the prospective EvAluate-TM study","volume":"96","author":"Nabieva","year":"2018","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.japh.2021.12.001_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021505","article-title":"Identifying prevalence and risk factors for metformin non-persistence: a retrospective cohort study using an electronic health record","volume":"8","author":"Flory","year":"2018","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.japh.2021.12.001_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J\u00a0Psychosom Res"},{"issue":"1","key":"10.1016\/j.japh.2021.12.001_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1345\/aph.1K073","article-title":"Risk factors for self-reported adverse drug events among medicare enrollees","volume":"42","author":"Oladimeji","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.japh.2021.12.001_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0738-3991(99)00083-X","article-title":"Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment","volume":"40","author":"Bultman","year":"2000","journal-title":"Patient Educ Couns"},{"issue":"3","key":"10.1016\/j.japh.2021.12.001_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pec.2010.06.033","article-title":"\u2018\u2018Practicing medicine\u2019\u2019: patient perceptions of physician communication and the process of prescription","volume":"80","author":"Ledford","year":"2010","journal-title":"Patient Educ Couns"},{"issue":"9","key":"10.1016\/j.japh.2021.12.001_bib21","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1592\/phco.22.13.1163.33512","article-title":"Development and validation of a survey to assess barriers to drug use in patients with chronic heart failure","volume":"22","author":"Simpson","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.japh.2021.12.001_bib22","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1345\/aph.1K209","article-title":"Factors related to adherence to statin therapy","volume":"41","author":"McGinnis","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.japh.2021.12.001_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1185\/03007990802619425","article-title":"The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease","volume":"25","author":"McHorney","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.japh.2021.12.001_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"1999","journal-title":"Psychol Health"},{"issue":"3","key":"10.1016\/j.japh.2021.12.001_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1503\/cmaj.111270","article-title":"The effect of cost on adherence to prescription medications in Canada","volume":"184","author":"Law","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.japh.2021.12.001_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fpubh.2018.00149","article-title":"Devleloping and validating scales for health, social, and behavioural reserach: a primer","volume":"6","author":"Boateng","year":"2018","journal-title":"Front Public Health"},{"key":"10.1016\/j.japh.2021.12.001_bib27","series-title":"Internet, Mail, and Mixed-Mode: the Tailored Design Method","author":"Dillman","year":"2009"},{"issue":"1","key":"10.1016\/j.japh.2021.12.001_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.japh.2021.12.001_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.2015.11082","article-title":"Evaluating discrimination of risk prediction models: the C statistic","volume":"314","author":"Pencina","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.japh.2021.12.001_bib30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.pec.2020.09.001","article-title":"Relationship between beliefs about medicines and adherence in elderly patients with cardiovascular and respiratory diseases: a cross-sectional study in Romania","volume":"104","author":"Sipos","year":"2021","journal-title":"Patient Educ Couns"},{"issue":"2","key":"10.1016\/j.japh.2021.12.001_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010035","article-title":"Medication-related burden and patients\u2019 lived experience with medicine: a systematic review and metasynthesis of qualitative studies","volume":"6","author":"Mohammed","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.japh.2021.12.001_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.socscimed.2004.11.063","article-title":"Resisting medicines: a synthesis of qualitative studies of medicine taking","volume":"61","author":"Pound","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.japh.2021.12.001_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3953","article-title":"Lay perspectives on hypertension and drug adherence: systematic review of qualitative research","volume":"345","author":"Marshall","year":"2012","journal-title":"BMJ"},{"issue":"22","key":"10.1016\/j.japh.2021.12.001_bib34","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"Wood","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1511","key":"10.1016\/j.japh.2021.12.001_bib35","first-page":"21","article-title":"Utilisation and maintenance of high-intensity statins following acute coronary syndrome and coronary angiography: opportunities to improve care (ANZACS-QI 26)","volume":"133","author":"Kerr","year":"2020","journal-title":"N.\u00a0Z. Med J"},{"issue":"1\u20132","key":"10.1016\/j.japh.2021.12.001_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000493530","article-title":"Medication adherence of statin users after acute ischemic stroke","volume":"80","author":"Chung","year":"2018","journal-title":"Eur Neurol"},{"issue":"6","key":"10.1016\/j.japh.2021.12.001_bib37","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/03007995.2017.1417242","article-title":"Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands","volume":"34","author":"Alfian","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.japh.2021.12.001_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/YIC.0b013e32833db42e","article-title":"Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder","volume":"25","author":"Liu","year":"2010","journal-title":"Int Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.japh.2021.12.001_bib39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/clc.22343","article-title":"Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-Intensity statin therapy? Implications of the 2013 American College of Cardiology\/American Heart Association cholesterol management guidelines","volume":"37","author":"Virani","year":"2014","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1016\/j.japh.2021.12.001_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1532-5415.2008.02133.x","article-title":"Which providers should communicate which critical information about a new medication? Patient, pharmacists, and physician perspectives","volume":"57","author":"Tarn","year":"2009","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.japh.2021.12.001_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/15265161.2011.652798","article-title":"To tell the truth, the whole truth, may do patients harm: the problem of the nocebo effect for informed consent","volume":"12","author":"Wells","year":"2012","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.japh.2021.12.001_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00167","article-title":"Can positive framing reduce Nocebo side effects? Current evidence and recommendation for future research","volume":"10","author":"Barnes","year":"2019","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.japh.2021.12.001_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1211\/0022357044120","article-title":"Interpretation of recommended risk terms: differences between doctors and lay people","volume":"12","author":"Berry","year":"2004","journal-title":"Int J Pharm Pract"},{"issue":"11","key":"10.1016\/j.japh.2021.12.001_bib44","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00005650-199911000-00009","article-title":"Asking questions about medication: analysis of physician-patient interactions and physician perceptions","volume":"37","author":"Sleath","year":"1999","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.japh.2021.12.001_bib45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archinte.161.5.706","article-title":"How much information about adverse effects of medication do patients want from physicians?","volume":"161","author":"Ziegler","year":"2001","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.japh.2021.12.001_bib46","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/fampra\/cmx023","article-title":"How do stroke survivors and their carers use practitioners\u2019 advice on secondary prevention medications? Qualitative study of an online forum","volume":"34","author":"Izuka","year":"2017","journal-title":"Fam Pract"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912100546X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912100546X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:50:22Z","timestamp":1761544222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431912100546X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S154431912100546X"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2021.12.001","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with early nonpersistence among patients experiencing side effects from a new medication","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2021.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}